AliveGen USA, Inc., founded in 2014, is a privately held clinical-stage biopharmaceutical company located in Thousand Oaks, California. We are focused on the discovery and development of novel biotherapeutics to combat the debilitating muscle and bone loss and the loss of functional capacity, as occurs in various neuromuscular diseases, cancer cachexia, congestive heart failure, geriatric sarcopenia and frailty, as well as in other chronic diseases, for which no approved therapies are currently available.